Patients face safety risks with counterfeit and compounded prescription weight-loss drugs

Patients face safety risks with counterfeit and compounded prescription weight-loss drugs Officials warn of counterfeit and compounding pharmacy concerns as demand for weight-loss medicines surges. Demand is skyrocketing for FDA-approved medicines that provide incredible benefits to patients living with diabetes and obesity. The injectables – GLP-1s like semaglutide and incretins that are commonly known as…

[...]

Lawsuits filed against businesses selling compounded injectables for diabetes and weight-loss

Lawsuits filed against businesses selling compounded injectables for diabetes and weight-loss Novo Nordisk and Eli Lilly, who developed and won FDA approval for their blockbuster weight-loss and diabetes medicines, Ozempic, Wegovy, Mounjaro and Zepbound, have been suing businesses who they say are marketing compounded versions of these drugs with false claims.  These medical spas, wellness…

[...]